Postmenopausal Vaginal Bleeding with Endometrial Hyperplasia with Atypia — Suitable for Surgery

Postmenopausal vaginal bleeding in the setting of endometrial hyperplasia with atypia represents a high-risk clinical scenario that requires prompt, structured management. When the patient is a suitable surgical candidate, an evidence-based protocol guides the preferred first-line approach.

Endometrial hyperplasia with atypia carries a significant risk of malignant progression: approximately 28% of patients with this condition will develop endometrial cancer over 20 years. Because of this risk, suitable postmenopausal women should be offered surgical management as the first-line option rather than conservative alternatives.

First-Line Management

For eligible postmenopausal women, the recommended approach is surgical and targets both the uterus and, given the postmenopausal context, additional structures to reduce long-term oncological risk. The full protocol — including the specific procedure scope, candidacy criteria, and decision pathway — is available via the link below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.ogrm.2025.09.009

As discussed previously, EH with atypia has a higher risk of progressing to endometrial cancer.
28% of patients with EH with atypia will develop endometrial cancer over 20 years.
For this reason, suitable women should be offered surgical management as first line.
A total hysterectomy is recommended and bilateral salpingo-ophorectomy in postmenopausal women to reduce future ovarian cancer risk.

View source ↗